Biolase Inc

NASDAQ: BIOL    
Share price (5/17/24): $0.16    
Market cap (5/17/24): $5.310 million

Credit Agreements Filter

EX-10.27
from 10-K 82 pages Eleventh Amendment to Credit Agreement
12/34/56
EX-10.1
from 8-K 178 pages Tenth Amendment to Credit Agreement
12/34/56
EX-10.1
from 10-Q 173 pages Ninth Amendment to Credit Agreement
12/34/56
EX-10.32
from 10-K 14 pages Eighth Amendment to Credit Agreement Recitals Agreement
12/34/56
EX-10.41
from 10-K 7 pages Seventh Amendment to Credit Agreement
12/34/56
EX-10.8
from 10-Q 9 pages Sixth Amendment to Credit Agreement
12/34/56
EX-10.5
from 10-Q 2 pages U.S. Small Business Administration Note (Secured Disaster Loans) Date: 05.22.2020 Loan Amount: $150,000.00 Annual Interest Rate: 3.75%
12/34/56
EX-10.3
from 10-Q 11 pages First Amendment to Loan and Security Agreement
12/34/56
EX-10.2
from 10-Q 6 pages Loan Authorization and Agreement
12/34/56
EX-10.1
from 10-Q 8 pages Fifth Amendment to Credit Agreement
12/34/56
EX-10.30
from S-1 8 pages Fifth Amendment to Credit Agreement
12/34/56
EX-10.29
from 10-K 8 pages Fourth Amendment to Credit Agreement
12/34/56
EX-10.5
from 10-Q 8 pages Third Amendment to Credit Agreement
12/34/56
EX-10.1
from 8-K 32 pages Loan and Security Agreement
12/34/56
EX-10.35
from S-1/A 8 pages Second Amendment to Credit Agreement
12/34/56
EX-10.8
from 10-Q 8 pages First Amendment to Credit Agreement
12/34/56
EX-10.6
from 10-Q 101 pages Credit Agreement Among Biolase, Inc., as Borrower, Swk Funding LLC, as Agent, Sole Lead Arranger and Sole Bookrunner, and the Financial Institutions Party Hereto From Time to Time as Lenders Dated as of November 9, 2018
12/34/56
EX-10.2
from 8-K 1 page Amendment No. 2 to Master Revolving Note
12/34/56
EX-10
from 10-Q 2 pages Amendment No. 1 to Master Revolving Note
12/34/56
EX-10
from 10-Q 5 pages Amendment No. 4 to Loan and Security Agreement
12/34/56